On March 31, members from the School of Medicine and the Foundation for Angelman Syndrome Therapeutics convened to reflect on progress being made towards combating the neurodegenerative disease.
Next-generation treatments on the way for once-incurable diseases can be complicated to test and administer; ‘if we can’t get it to these patients, the science is lost’